For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. See /policies/research-use.
Swiss Pharma’s BPC-157 TB-500 SKU is a co-formulated research blend in one prefilled pen — not two separate vials, and not a recovery or sports product. If catalog taxonomy uses “Recovery Stack,” that label is taxonomy only — not an outcome claim. Do not put “Recovery Stack” in the journal title or URL.
Blend identity
| Field | Value |
|---|---|
| Page name | BPC-157 TB-500 Blend |
| Fill | 20 mg total (10 mg + 10 mg) |
| CAS (components) | BPC-157: 137525-51-0 · TB-500–class listing: 77591-33-4 |
| Format | Prefilled 3 mL pen, bacteriostatic water |
| Concentration | 6.67 mg/mL blend |
| Storage | Refrigerate 2–8 °C; keep upright; do not freeze; in-use up to 30 days after first use — discard if particulates form |
Follow packaging / live pen for 10+10. Do not invent a 15+15 fill.
Component identity (chemistry only)
BPC-157 — synthetic 15-amino-acid pentadecapeptide; research-material identity only.
TB-500 — trade label for thymosin-beta-4–related research materials (CAS as on packaging).
Both appear in published animal-model literature. This page does not claim tissue repair, healing, gut outcomes, or any therapeutic effect.
Lot, COA, HPLC / MS
For blends, documentation should ideally address both components:
- Chromatographic methods that can resolve component peaks where the method allows
- Mass confirmation consistent with each component’s expected identity
- Clear 10+10 mg ratio on the pen label
Match pen QR / lot to the COA. See /science. Do not invent purity % or batch IDs.
What this page still refuses
- “Recovery & healing protocol,” Wolverine, sports framing
- Injection schedules / load–taper–off cycles
- Side-effect lists
Links: Product: /product/bpc-157-tb-500, Catalog: /catalog, COA primer: /journal/research-peptides-uae-coa